GlassScriptPhysician profile
Ariail Gilbert Schmitz
NPI 1740724566
$1,910.25
in general payments reported to CMS, 2019-2025
13 companies · $827 in 2025
The $827 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.16 · 2022: $124 · 2023: $30.00 · 2024: $836 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.80 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.90 | 2024-2025 | |
| Amgen INC. | $427.20 | 2021-2025 | Evenity, Krystexxa, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.21 | 2024-2025 | Ofev |
| Aurinia Pharma U.S., INC. | $186.66 | 2024-2025 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $155.00 | 2023-2025 | Saphnelo |
| Genzyme Corporation | $124.29 | 2022 | |
| Janssen Biotech, INC. | $99.00 | 2024 | Tremfya |
| Medtronic, INC. | $64.78 | 2025 | Symplicity G3, Minimed 780g |
| Radius Health, INC. | $60.69 | 2024-2025 | Tymlos |
| Janssen Scientific Affairs, LLC | $43.81 | 2021 | |
| Mallinckrodt Hospital Products INC. | $25.95 | 2024 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $20.76 | 2025 | |
| Xeris Pharmaceuticals, INC. | $18.00 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariail Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.